| __timestamp | Pharming Group N.V. | Takeda Pharmaceutical Company Limited |
|---|---|---|
| Wednesday, January 1, 2014 | 14182353 | 382096000000 |
| Thursday, January 1, 2015 | 15503028 | 345927000000 |
| Friday, January 1, 2016 | 16183585 | 312303000000 |
| Sunday, January 1, 2017 | 22382849 | 325441000000 |
| Monday, January 1, 2018 | 33038206 | 368298000000 |
| Tuesday, January 1, 2019 | 31777040 | 492381000000 |
| Wednesday, January 1, 2020 | 41464134 | 455833000000 |
| Friday, January 1, 2021 | 67178053 | 526087000000 |
| Saturday, January 1, 2022 | 52531000 | 633325000000 |
| Sunday, January 1, 2023 | 68914000 | 729924000000 |
| Monday, January 1, 2024 | 729924000000 |
Unlocking the unknown
In the competitive world of pharmaceuticals, research and development (R&D) spending is a key indicator of innovation and future growth. Over the past decade, Takeda Pharmaceutical Company Limited and Pharming Group N.V. have showcased contrasting strategies in their R&D investments.
From 2014 to 2023, Takeda's R&D expenses have surged by approximately 91%, reaching a staggering $730 billion in 2023. This reflects Takeda's commitment to maintaining its position as a global leader in the pharmaceutical industry. In contrast, Pharming Group N.V. has seen a more modest increase of around 386% in the same period, with R&D spending peaking at $69 million in 2023.
While Takeda's investment dwarfs that of Pharming, the latter's rapid growth in R&D spending highlights its ambition to expand its footprint in the industry. The data for 2024 remains incomplete, leaving room for speculation on future trends.
Analyzing R&D Budgets: Zoetis Inc. vs Takeda Pharmaceutical Company Limited
R&D Spending Showdown: Takeda Pharmaceutical Company Limited vs United Therapeutics Corporation
Who Generates Higher Gross Profit? Takeda Pharmaceutical Company Limited or Pharming Group N.V.
R&D Insights: How Takeda Pharmaceutical Company Limited and Exelixis, Inc. Allocate Funds
Analyzing R&D Budgets: Takeda Pharmaceutical Company Limited vs Veracyte, Inc.
Research and Development Expenses Breakdown: Takeda Pharmaceutical Company Limited vs Iovance Biotherapeutics, Inc.
Research and Development Investment: Takeda Pharmaceutical Company Limited vs BioCryst Pharmaceuticals, Inc.
BeiGene, Ltd. vs Pharming Group N.V.: Strategic Focus on R&D Spending
Research and Development: Comparing Key Metrics for Halozyme Therapeutics, Inc. and Pharming Group N.V.
Pharming Group N.V. vs ADMA Biologics, Inc.: Strategic Focus on R&D Spending
Analyzing R&D Budgets: Pharming Group N.V. vs Amneal Pharmaceuticals, Inc.
Who Prioritizes Innovation? R&D Spending Compared for Pharming Group N.V. and Ligand Pharmaceuticals Incorporated